Dr. Emilia Neuwirt

Dr. Emilia Neuwirt is a Co-Founder and CEO of EMUNO Therapeutics GmbH since May 2024 and has been a Postdoctoral Scientist focusing on Innate Immunity and Metabolism at Universitätsklinikum Freiburg since September 2017. Dr. Neuwirt completed the doctoral research in the same field, emphasizing expertise in biological sciences. Professional experience includes working as a pharmacist at various pharmacies, including Apotheke Im Kaufland & City Apotheke Freiburg, and participating in the Kreisimpfzentrum Kenzingen. Dr. Neuwirt has a comprehensive educational background with a Doctorate in Biology from The University of Freiburg, as well as a German Pharmaceutical License and a Diploma in Pharmacy from the same institution. Academic training includes a student assistant position in Pharmaceutical Chemistry at Albert-Ludwigs-Universität Freiburg im Breisgau and foundational education culminating in an Abitur from Fürstenberg-Gymnasium Donaueschingen.